Form D · Pharmaceuticals

Targeted Medical Pharma, Inc.

Los Angeles, CA · CIK 0001420030

Offering snapshot reported Feb 15, 2011 · SEC filing

Reported sold
$1
Offering amount: $1
Investors reported
40
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 31, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 15, 2011Initial$1No comparison40SEC filing
Jan 24, 2011Amendment$900,000No comparison316SEC filing
Oct 13, 2010InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-155416
This offering relates to an exchange of securities pursuant to a merger transaction as disclosed in the Issuer's Form 8-K filed with the SEC on EDGAR on February 3, 2011.

Source: Form D, filed Feb 15, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Amir Blachman Executive
John H. Bluher Director
Timothy J Brasel Director, Executive
Elizabeth Charuvastra Director
Maurice J. De Wald Director
Kim Giffoni Director, Executive
Amir F Heshmatpour Director, Executive
Arthur R. Nemiroff Director
William E. Shell, Md Director, Executive
Steve B. Warnecke Executive
Donald J. Webster Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2980 Beverly Glen Circle Suite 301
Los Angeles, CA, 90077